Gains of CCND3 gene in ocular adnexal MALT lymphomas: An integrated analysis

British Journal of Haematology

Volumn 160, Issue 5, 2013, Pages 719-722

  Li, Zhi Ming ^a,b   Spagnuolo, Lorenzo ^c   Mensah, Afua A ^a   Rinaldi, Andrea ^a   Bhagat, Govind ^d   Zucca, Emanuele ^e   Doglioni, Claudio ^c   Ferreri, Andrés J M ^c   Ponzoni, Maurilio ^c   Bertoni, Francesco ^a,e  

^a INSTITUTE OF ONCOLOGY RESEARCH   (Switzerland)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d NewYork Presbyterian Hospital   (United States)

^e ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

Author keywords

Arrays; B cells; Cancer; Cancer genetics; Malignant lymphomas

Indexed keywords

CYCLIN D3;

CCND3 GENE; CHROMOSOME 6P; DNA SEQUENCE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; GENETIC GAIN; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; MARGINAL ZONE LYMPHOMA; OCULAR ADNEXAL MALT LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

CELL NUCLEUS; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 6; CYCLIN D3; GENE DOSAGE; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, B-CELL, MARGINAL ZONE; NEOPLASM PROTEINS; ORBITAL NEOPLASMS;

EID: 84873995829     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12161     Document Type: Letter

References (9)

1. Bertoni, F., Coiffier, B., Salles, G., Stathis, A., Traverse-Glehen, A., Thieblemont, C. & Zucca, E. (2011) MALT lymphomas: pathogenesis can drive treatment. Oncology (Williston Park), 25, 1134-1142, 1147.
2. Chanudet, E., Ye, H., Ferry, J., Bacon, C.M., Adam, P., Muller-Hermelink, H.K., Radford, J., Pileri, S.A., Ichimura, K., Collins, V.P., Hamoudi, R.A., Nicholson, A.G., Wotherspoon, A.C., Isaacson, P.G. & Du, M.Q. (2009) A20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands. Journal of Pathology, 217, 420-430.
3. Kasugai, Y., Tagawa, H., Kameoka, Y., Morishima, Y., Nakamura, S. & Seto, M. (2005) Identification of CCND3 and BYSL as candidate targets for the 6p21 amplification in diffuse large B-cell lymphoma. Clinical Cancer Research, 11, 8265-8272.
4. Kwee, I., Rancoita, P.M., Rinaldi, A., Ferreri, A.J., Bhagat, G., Gascoyne, R., Canzonieri, V., Gaidano, G., Doglioni, C., Zucca, E., Ponzoni, M. & Bertoni, F. (2011) Genomic profiles of MALT lymphomas: variability across anatomic sites. Haematologica, 96, 1064-1066.
5. Mensah, A.A., Rinaldi, A., Ponzoni, M., Canzonieri, V., Uccella, S., Rossi, D., Bhagat, G., Gaidano, G., Zucca, E. & Bertoni, F. (2011) Absence of NOTCH1 gene mutations in MALT lymphomas. British Journal of Haematology, 157, 382-384.
6. Morin, R.D., Mendez-Lago, M., Mungall, A.J., Goya, R., Mungall, K.L., Corbett, R.D., Johnson, N.A., Severson, T.M., Chiu, R., Field, M., Jackman, S., Krzywinski, M., Scott, D.W., Trinh, D.L., Tamura-Wells, J., Li, S., Firme, M.R., Rogic, S., Griffith, M., Chan, S., Yakovenko, O., Meyer, I.M., Zhao, E.Y., Smailus, D., Moksa, M., Chittaranjan, S., Rimsza, L., Brooks-Wilson, A., Spinelli, J.J., Ben-Neriah, S., Meissner, B., Woolcock, B., Boyle, M., McDonald, H., Tam, A., Zhao, Y., Delaney, A., Zeng, T., Tse, K., Butterfield, Y., Birol, I., Holt, R., Schein, J., Horsman, D.E., Moore, R., Jones, S.J., Connors, J.M., Hirst, M., Gascoyne, R.D. & Marra, M.A. (2011) Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature, 476, 298-303.
7. Rinaldi, A., Mian, M., Chigrinova, E., Arcaini, L., Bhagat, G., Novak, U., Rancoita, P.M., De Campos, C.P., Forconi, F., Gascoyne, R.D., Facchetti, F., Ponzoni, M., Govi, S., Ferreri, A.J., Mollejo, M., Piris, M.A., Baldini, L., Soulier, J., Thieblemont, C., Canzonieri, V., Gattei, V., Marasca, R., Franceschetti, S., Gaidano, G., Tucci, A., Uccella, S., Tibiletti, M.G., Dirnhofer, S., Tripodo, C., Doglioni, C., Dalla Favera, R., Cavalli, F., Zucca, E., Kwee, I. & Bertoni, F. (2011) Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome. Blood, 117, 1595-1604.
8. Schmitz, R., Young, R.M., Ceribelli, M., Jhavar, S., Xiao, W., Zhang, M., Wright, G., Shaffer, A.L., Hodson, D.J., Buras, E., Liu, X., Powell, J., Yang, Y., Xu, W., Zhao, H., Kohlhammer, H., Rosenwald, A., Kluin, P., Muller-Hermelink, H.K., Ott, G., Gascoyne, R.D., Connors, J.M., Rimsza, L.M., Campo, E., Jaffe, E.S., Delabie, J., Smeland, E.B., Ogwang, M.D., Reynolds, S.J., Fisher, R.I., Braziel, R.M., Tubbs, R.R., Cook, J.R., Weisenburger, D.D., Chan, W.C., Pittaluga, S., Wilson, W., Waldmann, T.A., Rowe, M., Mbulaiteye, S.M., Rickinson, A.B. & Staudt, L.M. (2012) Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature, 490, 116-120.
9. Sonoki, T., Harder, L., Horsman, D.E., Karran, L., Taniguchi, I., Willis, T.G., Gesk, S., Steinemann, D., Zucca, E., Schlegelberger, B., Sole, F., Mungall, A.J., Gascoyne, R.D., Siebert, R. & Dyer, M.J. (2001) Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies. Blood, 98, 2837-2844.